Subtype
Primary Malignant Liver Neoplasm
CI-CAN-00006507Explore in graph →
807 active trials14 approved drugs17 evidence items
- NCIt
- C34803
Loading cancer entity…
Subtype
CI-CAN-00006507Explore in graph →
Clinical trials
3,486 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (402)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05397860 | Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma Treatment | unknown | N/A | 120 | Seoul National University HospitalOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05391867 | Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma | unknown | N/A | 70 | Sir Salimullah Medical College Mitford HospitalOTHER_GOV | 1 | May 26, 2022 |
| clinicaltrials |
| NCT04487704 | Camrelizumab Utilization on Patients With Advanced Liver Cancer | unknown | N/A | 1,000 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT05339581 | IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation(iPLENTY-pvtt) | unknown | N/A | 78 | RenJi HospitalOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT05277675 | Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)(RANT) | unknown | N/A | 160 | Southwest Hospital, ChinaOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT04825470 | Liver Transplantation for Unresectable GIST Liver Metastases(TRANSGIST) | unknown | N/A | 50 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05270642 | Plan for Microwave Thermal Field | unknown | N/A | 5 | Chinese PLA General HospitalOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT03322280 | TACE Combined With Iodine-125 Seeds Implantation for HCC | unknown | N/A | 270 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT05247996 | TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma | unknown | N/A | 98 | The Central Hospital of Lishui CityOTHER | 0 | Feb 21, 2022 | clinicaltrials |
| NCT05242757 | Clinical Study of MAK Immune Cells in the Treatment of PHC | unknown | N/A | 12 | Zhongnan HospitalOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT02009176 | Laparoscope Anatomical and Aon-anatomical Hepatectomy | unknown | N/A | 110 | Shuguo Zheng, MDOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT05118451 | A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC | unknown | N/A | 420 | Zhujiang HospitalOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT05233358 | HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure | unknown | N/A | 176 | The Central Hospital of Lishui CityOTHER | 0 | Feb 10, 2022 | clinicaltrials |
| NCT05162898 | Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma. | unknown | N/A | 90 | Henan Cancer HospitalOTHER_GOV | 0 | Jan 27, 2022 | clinicaltrials |
| NCT03731910 | Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE | unknown | N/A | 35 | Seoul National University HospitalOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT04443049 | To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | unknown | N/A | 170 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT03591705 | TACE-HAIC vs. HAIC for Potentially Resectable HCC | unknown | N/A | 240 | Sun Yat-sen UniversityOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04531228 | TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial(Thalen) | unknown | N/A | 60 | Yunfei YuanOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT05053386 | Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma | unknown | N/A | 186 | Zhejiang Cancer HospitalOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT02921139 | Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)(TASABR) | unknown | N/A | 120 | Dalin Tzu Chi General HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT05009550 | ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation | unknown | N/A | 30 | TC Erciyes UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04961138 | Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma | unknown | N/A | 164 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Jul 14, 2021 | clinicaltrials |
| NCT04955119 | Fusion Imaging Contrast-enhanced Ultrasound LI-RADS | unknown | N/A | 132 | Tianjin Third Central HospitalOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT02964260 | RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma | unknown | N/A | 410 | Sun Yat-sen UniversityOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT04517227 | The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD) | unknown | N/A | 30 | Fudan UniversityOTHER | 0 | May 3, 2021 | clinicaltrials |
| NCT02556619 | Randomized Control Trial (RCT) of Early Palliative Care for HCC | unknown | N/A | 72 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 27, 2021 | clinicaltrials |
| NCT03342677 | Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility | unknown | N/A | 80 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT02806076 | RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode | unknown | N/A | 100 | Seoul National University HospitalOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT02854241 | Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance | unknown | N/A | 40 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT03742453 | Evaluation of Diagnostic Accuracy of CEUS for HCC Diagnosis | unknown | N/A | 117 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04331184 | RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes | unknown | N/A | 102 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04471272 | RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes | unknown | N/A | 120 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04738188 | Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria; | unknown | N/A | 226 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Feb 4, 2021 | clinicaltrials |
| NCT04640116 | TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites | unknown | N/A | 30 | Sun Yat-sen UniversityOTHER | 0 | Dec 19, 2020 | clinicaltrials |
| NCT04619342 | Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT) | unknown | N/A | 98 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT04181931 | Neo-TACE-HAIC for PVTT-HCC(NeoconceptC) | unknown | N/A | 320 | Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT04424043 | Neo-TACE-HAIC for BCLC B Stage HCC(NeoconceptB) | unknown | N/A | 280 | Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT03302403 | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | unknown | N/A | 18 | Kang YUOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04443322 | Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )(Dulect2020-1) | unknown | N/A | 20 | RenJi HospitalOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT03754192 | Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma(PERCAHEC) | unknown | N/A | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT04523467 | Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma | unknown | N/A | 320 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT04521491 | A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells | unknown | N/A | 184 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04494022 | Role of CEUS as a Secondary Diagnostic Modality | unknown | N/A | 120 | Seoul National University HospitalOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT04386772 | Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma | unknown | N/A | 56 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Jun 17, 2020 | clinicaltrials |
| NCT04434989 | SBRT Versus Ablation for Perivascular Hepatocellular Carcinoma(SAIL) | unknown | N/A | 170 | Sun Yat-sen UniversityOTHER | 1 | Jun 17, 2020 | clinicaltrials |
| NCT04414956 | Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma | unknown | N/A | 1,418 | Korea UniversityOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT03969576 | Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC) | unknown | N/A | 344 | Air Force Military Medical University, ChinaOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03211598 | Surefire Institutional DEB-TACE | unknown | N/A | 15 | Alexander KimOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT03790059 | Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma. | unknown | N/A | 160 | Southwest Hospital, ChinaOTHER | 1 | Oct 16, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jun 15, 2022source: clinicaltrials